Prior research on the potential role of cytokines found that IL-6 signaling can reprogram and alter T-cell immune responses ...

Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity ...

Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer ...

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have published a ...

Innovations in injectable drug packaging are transforming how medications are delivered, combining safety, convenience, and ...

Rhabdomyosarcoma (RMS) accounts for up to 10% of childhood cancers and nearly half of pediatric soft tissue sarcomas.

Starting with a study of how mutations affect sensitivity to 10 molecularly targeted drugs, researchers have laid the foundations for a prospective, systematic approach to understanding the genetic ...

Researchers at the University of Virginia have discovered a new mechanism driving drug resistance in pancreatic ductal adenocarcinoma, one of the deadliest cancers. Their groundbreaking findings could ...

Melanoma is the most common form of skin cancer, but for patients with advanced melanoma who no longer respond to standard ...

Colorectal cancer is one of the most common tumors among people over the age of 50. Although it is known to develop from ...